ArticleRheumatology (Oxford, England)2026

PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathies.

Emma M Austenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.